APA (7th ed.) Citation

Noguchi, R., Ono, T., Sasaki, K., Masuda, M., Kawai, A., Yoshimatsu, Y., & Kondo, T. (2025). Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. MDPI AG.

Chicago Style (17th ed.) Citation

Noguchi, Rei, Takuya Ono, Kazuki Sasaki, Mari Masuda, Akira Kawai, Yuki Yoshimatsu, and Tadashi Kondo. Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. MDPI AG, 2025.

MLA (9th ed.) Citation

Noguchi, Rei, et al. Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. MDPI AG, 2025.